Trade CORT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Corcept Therapeutics Incorporated (CORT) is trading at US$114.86, down 1.77% today as of Aug 28, 11:01 EDT. The company has a market capitalisation of US$13.22B. Over the past 52 weeks, CORT has traded between US$28.66 and US$126.38. On Syfe you can trade CORT with $0 commission and add it to your watchlist.
| Previous close | US$116.93 |
|---|---|
| Market cap | US$13.22B |
| P/E ratio | 33.15 |
| 52-week range | US$28.66 – US$126.38 |
| Volume | 638.56K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Corcept Therapeutics Incorporated
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Year: 2004
Corcept Therapeutics Incorporated (CORT) stock is trading at US$114.86, -1.77% from the previous close of US$116.93.
The market cap for Corcept Therapeutics Incorporated (CORT) stock is approximately US$13.22B.
The price-to-earnings ratio for Corcept Therapeutics Incorporated (CORT) is 33.15, based on the latest reported earnings.
The 52-week high for Corcept Therapeutics Incorporated (CORT) stock is US$126.38.
The 52-week low for Corcept Therapeutics Incorporated (CORT) stock is US$28.66.
Corcept Therapeutics Incorporated (CORT) does not currently pay a dividend.
Stay on top of CORT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
